Operating Metrics 營運指標
Medtronic plc (MDT) Operating Metrics 營運指標
Medtronic plc MDT 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-04-24
最新營運指標
- Cardiovascular Revenue
- $13,975M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Cardiac Rhythm & Heart Failure Revenue
- $7,503M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Structural Heart & Aortic Revenue
- $3,817M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Coronary & Peripheral Vascular Revenue
- $2,655M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Neuroscience Revenue
- $10,287M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Cranial & Spinal Technologies Revenue
- $5,223M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Specialty Therapies Revenue
- $2,998M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
- Neuromodulation Revenue
- $2,069M · 2026-04-24 來源：Medtronic plc、Medtronic plc、Medtronic plc、Medtronic plc
季度趨勢
| 指標 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular Revenue | $3,797M | $3,457M | $3,436M | $3,285M | $3,336M | $3,037M | $3,102M | $3,007M |
| Cardiac Rhythm & Heart Failure Revenue | $2,110M | $1,856M | $1,825M | $1,712M | $1,733M | $1,545M | $1,578M | $1,535M |
| Structural Heart & Aortic Revenue | $1,002M | $929M | $956M | $930M | $944M | $874M | $881M | $856M |
| Coronary & Peripheral Vascular Revenue | $685M | $672M | $655M | $643M | $659M | $618M | $643M | $616M |
| Neuroscience Revenue | $2,751M | $2,558M | $2,562M | $2,416M | $2,620M | $2,458M | $2,451M | $2,317M |
| Cranial & Spinal Technologies Revenue | $1,403M | $1,310M | $1,299M | $1,211M | $1,342M | $1,250M | $1,234M | $1,147M |
| Specialty Therapies Revenue | $806M | $746M | $744M | $702M | $759M | $732M | $737M | $713M |
| Neuromodulation Revenue | $542M | $503M | $520M | $504M | $520M | $476M | $480M | $457M |
| Medical Surgical Revenue | $2,388M | $2,173M | $2,171M | $2,083M | $2,212M | $2,072M | $2,128M | $1,996M |
| Surgical & Endoscopy Revenue | $1,820M | $1,654M | $1,679M | $1,612M | $1,709M | $1,596M | $1,649M | $1,544M |
資料來源
- Medtronic Reports Fourth Quarter and Full Year Fiscal 2026 Results · Medtronic plc · 2026-06-03
- Medtronic Reports Strong Third Quarter Fiscal 2026 Results · Medtronic plc · 2026-02-17
- Medtronic Reports Strong Second Quarter Fiscal 2026 Results · Medtronic plc · 2025-11-18
- Medtronic Reports First Quarter Fiscal 2026 Financial Results · Medtronic plc · 2025-08-19